Bristol-Myers Squibb Co
BMY
$45.56+0.20 (+0.44%)
Aug 8, 2025, 10:36 AM
Financials
| 52Week High | 63.33 | 52Week Low | 42.96 |
| Beta | 0.34 | Current Ratio Annual | 1.25 |
| Current Ratio Quarterly | 1.21 | Gross Margin TTM | 73.92 |
| Market Cap | 92.08B | Net Profit Margin TTM | 10.59 |
| Operating Margin TTM | 17.82 | Price To Book | 5.28 |
| Price To Earnings TTM | 18.23 | Price To Free Cash Flow TTM | 6.32 |
| Price To Sales TTM | 1.93 | Quick Ratio Annual | 1.15 |
| Quick Ratio Quarterly | 1.11 | Return On Assets TTM | 5.41 |
| Return On Equity TTM | 29.57 | Return On Investment TTM | 7.58 |
| Revenue Growth3Y | 1.36 | Revenue Growth5Y | 13.06 |
| Revenue Growth Quarterly Yoy | 0.56 | Revenue Growth TTMYoy | 2.57 |
| Revenue Per Share TTM | 23.41 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 2352 | 165 | 253 | 897 | 931 | 318 | 1.64B | $95.80B |
| Jun 30, 2025 | 1322 | 39 | 165 | 429 | 584 | 172 | 196.38M | $7.87B |
| Change | 1.03K(44%) | 126(76%) | 88(35%) | 468(52%) | 347(37%) | 146(46%) | 1.44B(88%) | $87.93B(92%) |